Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

Published:2008-01 Issue:1 Volume:108 Page:68-71
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Ramirez Pedro T.,Landen Charles N.,Coleman Robert L.,Milam Michael R.,Levenback Charles,Johnston Taren A.,Gershenson David M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference12 articles.

1. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

2. Prognostic features of importance for phase II studies in platinum-pretreated ovarian cancer patients, abstract;Vermorken,1996

3. Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors;Mimnaugh;Biochem Pharmacol,2000

4. Protease inhibitor-induced apoptosis: accumulation of wt 53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition;An;Leukemia,2000

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer;PLOS ONE;2024-07-11

2. Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway;Journal of Pharmacology and Experimental Therapeutics;2021-11-05

3. Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo;Neoplasia;2021-01

4. Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties;PLOS ONE;2020-01-15

5. Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma;Cancer Research;2019-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3